Clinical Trials in Nashville

Showing 15741-15760 of 20,298 trials

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

NCT01352884

This is a Phase 1, open-label, multi-center, first time in human study of AMP-224 in adult patients with cancer that is not responding to standard therapy. This study will be conducted in two stages consisting of a Dose-Escalation stage and an Expansion Stage.

Cancer

MedImmune LLC44 participantsStarted Mar 2011

Detroit, Michigan, United States • New York, New York, United States • Huntersville, North Carolina, United States +1 more locations

COMPLETEDPhase 4< 1 mile

Bipolar Study in Adults at Least 18 Years of Age

NCT00067938

Bipolar study of tolerability, clinical response and patient satisfaction

Bipolar Disorder

GlaxoSmithKline1,200 participantsStarted Aug 2003

Albertville, Alabama, United States • Anniston, Alabama, United States • Birmingham, Alabama, United States +305 more locations

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

Bipolar Study in Adults at Least 18 Years of Age

Find Trials by Condition in Nashville

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme

Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

Sensor Optimization of Cardiac Resynchronization Therapy Response

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73

Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects